<DOC>
	<DOCNO>NCT00774787</DOCNO>
	<brief_summary>The purpose study determine use topical imiquimod cream cryotherapy actinic keratoses reduces total number lesion ( treat cryotherapy new one ) follow-up .</brief_summary>
	<brief_title>Topical Imiquimod Cream Combination With Cryotherapy Treatment Actinic Keratoses</brief_title>
	<detailed_description>Actinic keratoses common skin lesion associate excess sun exposure . Over time , small risk lesion may progress skin cancer . Since one predict actinic keratosis progress , standard care treat lesion . The commonly use method treat actinic keratoses United States cryotherapy , use intense cold freeze destroy lesion . Efficacy appear relate long one freeze lesion , increase freeze time may result increase pain and/or skin pigment change treatment . Cryotherapy provider-administered `` focal '' treatment treat lesion freeze . There may early actinic keratoses skin surround treat lesion easily see ; may progress time visible lesion . There several patient-administered topical treatment actinic keratoses apply treatment area `` field '' rather specific lesion . Imiquimod 5 % cream one treatment , approve United States treatment AKs dose regimen 1 packet apply 2 time per week 25 cm2 area 2x/week 16 week . The study use split-face design ( one side face treat side untreated ) explore whether 4-week course topical imiquimod 5 % cream cryotherapy actinic keratoses reduces total number lesion ( treat cryotherapy new one ) treatment area follow-up .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>A clinical diagnosis actinic keratoses Actinic keratoses two reasonably bilaterally symmetric area face and/or bald scalp : area minimum 25 cm^2 maximum 50 cm^2 area least 6 typical , nonhypertrophic target AKs target AK lesion count +/ 1 lesion area area patient distinguish respect study drug application Able comply study requirement Are willing able give write informed consent Uncontrolled intercurrent chronic illness Systemic immunocompromise due disease treatment Clinically relevant systemic autoimmune disease Pregnant nursing Dermatologic disease and/or condition treatment area may exacerbate imiquimod cause difficulty examination Participation another clinical study Allergies imiquimod excipients cream Treatment within past 90 day follow : Psoralens plus ultraviolet A therapy Ultraviolet B therapy Systemic immunomodulators ( e.g . oral parenteral corticosteroid great physiologic dos , interferon , antiTNF agent , cytokine ) Chemotherapeutic cytotoxic agent ; Investigational agent Treatment within past 30 day follow : Surgical excision Photodynamic therapy Curettage Topical corticosteroid Laser Dermabrasion Chemical peel Imiquimod 5 % cream Topical retinoids 5fluorouracil Masoprocol Pimecrolimus tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Combination treatment</keyword>
	<keyword>Imiquimod</keyword>
	<keyword>Cryotherapy</keyword>
</DOC>